On 2023-11-09, Evelo Biosciences, Inc. (EVLO) announced earnings per share of $-0.66 for the fiscal quarter ending 2023-09-30, beating the average analyst estimate of $-1.34.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
---|---|---|---|
2023-11-09 | 2023-09-30 | $-1.34 | $-0.66 |
2023-08-14 | 2023-06-30 | $-4.33 | $-3.55 |
2023-05-15 | 2023-03-31 | -- | $-4.60 |
2023-03-16 | 2022-12-31 | $-6.00 | $-4.20 |
2022-11-14 | 2022-09-30 | $-6.60 | $-5.60 |
2022-08-11 | 2022-06-30 | $-11.20 | $-8.00 |
2022-05-12 | 2022-03-31 | $-11.60 | $-11.20 |
2022-03-24 | 2021-12-31 | $-12.20 | $-10.80 |
2021-10-28 | 2021-09-30 | $-11.40 | $-12.60 |
2021-07-29 | 2021-06-30 | $-10.80 | $-11.80 |
2021-04-29 | 2021-03-31 | $-10.60 | $-11.00 |
2021-03-09 | 2020-12-31 | $-9.60 | $-12.40 |
2020-10-29 | 2020-09-30 | $-10.00 | $-9.00 |
2020-07-30 | 2020-06-30 | $-14.20 | $-12.60 |
2020-05-11 | 2020-03-31 | $-14.20 | $-14.20 |
2020-02-13 | 2019-12-31 | $-13.00 | $-14.00 |
2019-11-05 | 2019-09-30 | $-13.40 | $-13.40 |
2019-08-06 | 2019-06-30 | $-13.00 | $-13.00 |
2019-05-02 | 2019-03-31 | -- | $-12.80 |
2019-02-14 | 2018-12-31 | -- | $-9.80 |
2018-11-01 | 2018-09-30 | -- | $-10.00 |
2018-08-02 | 2018-06-30 | -- | $-17.00 |
2018-05-31 | 2018-03-31 | -- | $-65.80 |